- Conditions
- Gastroparesis
- Interventions
- Domperidone
- Drug
- Lead sponsor
- Arnold, George, M.D.
- Individual
- Eligibility
- 18 Years and older
- Enrollment
- 75 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2018
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–8
of 8
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Gastroparesis
- Interventions
- Domperidone Oral Product
- Drug
- Lead sponsor
- Wake Forest University Health Sciences
- Other
- Eligibility
- 12 Years and older
- U.S. locations
- 1
- States / cities
- Green Bay, Wisconsin
- Conditions
- Patients With Gastroparesis Who Have Failed Standard Therapy
- Interventions
- Domperidone
- Drug
- Lead sponsor
- Ron Schey
- Other
- Eligibility
- 18 Years to 60 Years
- Enrollment
- 9 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2014
- U.S. locations
- 1
- States / cities
- Iowa City, Iowa
- Conditions
- Gastroparesis, Gastroesophageal Reflux
- Interventions
- domperidone
- Drug
- Lead sponsor
- David J. Lederer, M.D.
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 6 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2010
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Diabetic Gastroparesis
- Interventions
- CIN-102 Dose 1, CIN-102 Dose 2, Placebo for CIN-102
- Drug
- Lead sponsor
- CinDome Pharma, Inc.
- Industry
- Eligibility
- 18 Years to 70 Years
- Enrollment
- 2 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020
- U.S. locations
- 1
- States / cities
- El Paso, Texas
- Conditions
- Oncology Patients With Gastroparesis
- Interventions
- Oral Domperidone
- Drug
- Lead sponsor
- Eastern Regional Medical Center
- Other
- Eligibility
- 18 Years and older
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
- Conditions
- Gastroparesis, GERD, Esophagitis, Dyspepsia, Chronic Idiopathic Constipation, Nausea, Vomiting
- Interventions
- Domperidone
- Drug
- Lead sponsor
- Carle Physician Group
- Individual
- Eligibility
- 18 Years and older
- Enrollment
- 42 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2012
- U.S. locations
- 1
- States / cities
- Urbana, Illinois
- Conditions
- Gastroesophageal Reflux Disease, GERD, Gastroparesis
- Interventions
- Domperidone
- Drug
- Lead sponsor
- Scott Gabbard, MD
- Other
- Eligibility
- 18 Years and older
- U.S. locations
- 2
- States / cities
- Weston, Florida • Cleveland, Ohio